Silence Therapeutics plc (SLN) Capital expenditures 2022–2025
Silence Therapeutics plc (SLN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$55,000FY2025 · since FY2022: $173,000 → $55,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $55,000 | -73.9% |
| FY2024 | $211,000 | +276.8% |
| FY2023 | $56,000 | -67.6% |
| FY2022 | $173,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice